The IPO BillionToOne has more than doubled its revenue last year — Stock with breakout from IPO base!

BillionToOne has only been on the stock exchange since November 6, but it has developed nicely since then and left the IPO base on November 24. The stock started trading at $60, then doubled within a day, fell back significantly, and is now approaching a new all-time high, where one could follow procyclically. The company has a patented cancer diagnostic technology that goes beyond current limitations in diagnostics and can detect diseases molecule by molecule. A small anecdote about the company name: it refers to the company's technology – because...